1345 related articles for article (PubMed ID: 31534039)
1. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
2. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
Horner SM; Park HS; Gale M
J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
[TBL] [Abstract][Full Text] [Related]
3. Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant.
Dalrymple NA; Cimica V; Mackow ER
mBio; 2015 May; 6(3):e00553-15. PubMed ID: 25968648
[TBL] [Abstract][Full Text] [Related]
4. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
Johnson CL; Owen DM; Gale M
J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
[TBL] [Abstract][Full Text] [Related]
5. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
[TBL] [Abstract][Full Text] [Related]
6. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.
Oshiumi H; Miyashita M; Matsumoto M; Seya T
PLoS Pathog; 2013; 9(8):e1003533. PubMed ID: 23950712
[TBL] [Abstract][Full Text] [Related]
7. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
8. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.
Chen Z; Benureau Y; Rijnbrand R; Yi J; Wang T; Warter L; Lanford RE; Weinman SA; Lemon SM; Martin A; Li K
J Virol; 2007 Jan; 81(2):964-76. PubMed ID: 17093192
[TBL] [Abstract][Full Text] [Related]
9. MDA5 plays a critical role in interferon response during hepatitis C virus infection.
Cao X; Ding Q; Lu J; Tao W; Huang B; Zhao Y; Niu J; Liu YJ; Zhong J
J Hepatol; 2015 Apr; 62(4):771-8. PubMed ID: 25463548
[TBL] [Abstract][Full Text] [Related]
10. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
[TBL] [Abstract][Full Text] [Related]
11. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus reveals a novel early control in acute immune response.
Arnaud N; Dabo S; Akazawa D; Fukasawa M; Shinkai-Ouchi F; Hugon J; Wakita T; Meurs EF
PLoS Pathog; 2011 Oct; 7(10):e1002289. PubMed ID: 22022264
[TBL] [Abstract][Full Text] [Related]
13. Zika Virus Proteins NS2A and NS4A Are Major Antagonists that Reduce IFN-β Promoter Activity Induced by the MDA5/RIG-I Signaling Pathway.
Ngueyen TTN; Kim SJ; Lee JY; Myoung J
J Microbiol Biotechnol; 2019 Oct; 29(10):1665-1674. PubMed ID: 31581385
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Kinase Activities In Vitro by Hepatitis C Virus Protease NS3/NS4A Mediated-Cleavage of Key Immune Modulator Kinases.
Abdullah MAF; McWhirter SM; Suo Z
Cells; 2023 Jan; 12(3):. PubMed ID: 36766748
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.
Welsch C; Haselow K; Gouttenoire J; Schneider M; Morikawa K; Martinez Y; Susser S; Sarrazin C; Zeuzem S; Antes I; Moradpour D; Lange CM
J Hepatol; 2015 Apr; 62(4):779-84. PubMed ID: 25463536
[TBL] [Abstract][Full Text] [Related]
17. [Chronic hepatitis C virus infection attenuates host antiviral innate immune response].
Oshiumi H; Matsumoto M; Seya T
Nihon Rinsho; 2015 Feb; 73(2):234-8. PubMed ID: 25764676
[TBL] [Abstract][Full Text] [Related]
18. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
Dansako H; Ikeda M; Kato N
FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
[TBL] [Abstract][Full Text] [Related]
19. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response.
Ferreira AR; Magalhães AC; Camões F; Gouveia A; Vieira M; Kagan JC; Ribeiro D
J Cell Mol Med; 2016 Apr; 20(4):750-7. PubMed ID: 26865163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
